INS and type 2 diabetes mellitus: The efficacy of Remo in treating T2DM has been shown in numerous phase II clinical trials through its ability to reduce postprandial glucose excursions, improving HbA1c, improving insulin sensitivity, and enhancing pancreatic beta cell function, with clinically proven insulin-sensitizing properties (Nakano et al., 2015).